151 related articles for article (PubMed ID: 33638929)
1. Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.
Nahm JH; Lee HS; Kim H; Yim SY; Shin JH; Yoo JE; Ahn SH; Choi JS; Lee JS; Park YN
Liver Int; 2021 Jul; 41(7):1662-1674. PubMed ID: 33638929
[TBL] [Abstract][Full Text] [Related]
2. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
3. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
[TBL] [Abstract][Full Text] [Related]
5. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
[TBL] [Abstract][Full Text] [Related]
6. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.
Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
J Hepatol; 2019 Mar; 70(3):440-448. PubMed ID: 30389551
[TBL] [Abstract][Full Text] [Related]
7. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
9. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.
Kim SU; Jung KS; Lee S; Park JY; Kim DY; Ahn SH; Choi GH; Kim KS; Choi JS; Han KH; Park YN
Liver Int; 2014 Aug; 34(7):1008-17. PubMed ID: 24483989
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
[TBL] [Abstract][Full Text] [Related]
11. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
13. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
[TBL] [Abstract][Full Text] [Related]
15. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.
Imamura H; Matsuyama Y; Tanaka E; Ohkubo T; Hasegawa K; Miyagawa S; Sugawara Y; Minagawa M; Takayama T; Kawasaki S; Makuuchi M
J Hepatol; 2003 Feb; 38(2):200-7. PubMed ID: 12547409
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
17. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.
Notake T; Kobayashi A; Shinkawa H; Kawahara T; Shimizu A; Yokoyama T; Hasegawa K; Kokudo N; Matsuyama Y; Makuuchi M; Miyagawa SI
Int J Clin Oncol; 2017 Aug; 22(4):715-725. PubMed ID: 28303401
[TBL] [Abstract][Full Text] [Related]
18. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.
Cheng Z; Yang P; Qu S; Zhou J; Yang J; Yang X; Xia Y; Li J; Wang K; Yan Z; Wu D; Zhang B; Hüser N; Shen F
HPB (Oxford); 2015 May; 17(5):422-7. PubMed ID: 25421805
[TBL] [Abstract][Full Text] [Related]
20. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
